Zhixiang Jintai (688443.SH): The injection of ciliximab will be included in the 2025 National Medical Insurance Catalog.

Zhixin Financial News APP, Zhixiang Jintai (688443.SH) announced that the company's independently developed siltuximab injection (Jinlixi) has been successfully included in the "National Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance Drug List" (hereinafter referred to as the "National Medical Insurance List"). The new version of the National Medical Insurance List will be officially implemented from January 1, 2026.